| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9377766 | Biological Psychiatry | 2005 | 9 Pages |
Abstract
These findings 1) indicate that risperidone and olanzapine efficacy might be augmented with D-serine adjuvant treatment; 2) confirm D-serine efficacy against main schizophrenia symptom domains; and 3) warrant the assessment of D-serine antipsychotic monotherapy for this illness.
Related Topics
Life Sciences
Neuroscience
Biological Psychiatry
Authors
Uriel Heresco-Levy, Daniel C. Javitt, Richard Ebstein, Agnes Vass, Pesach Lichtenberg, Gali Bar, Sara Catinari, Marina Ermilov,